CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Katja Lohmann

ORCID: 0000-0002-5121-1460↗

Public evidence

1 connected articles

The role of dopaminergic medication and specific pathway alterations in idiopathic and <i>PRKN/PINK1</i>-mediated Parkinson's disease.2025 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Katja Lohmann - Medical Cannabis Research Engine